However, when comparing the post-procedural prevalence with 1-year prior to thrombectomy, we observed no change, suggesting that thrombectomy does not result in added headache burden in the larger scope of life-time headache evolution.
Although the scope, character and content of headache practice have changed markedly during recent years, the principal driver has been the introduction of new drugs.
Most patients suffering from headache who receive timely and good-quality health care can expect this care to be effective, restoring quality of life [12], but good quality in health care has not been the automatic result of the marked changes in scope, character and content of headache practice and care that have occurred during the last years.
Understanding the scale and scope of the burden of headache disorders is the basis of health-needs assessment, of planning effective health services and of appropriate resource-allocation for what is and should be seen as a public-health priority [20].
Amongst the several reasons contributing to this is a lack of political awareness of the scope and scale of the burden of headache, which itself is attributable to incomplete knowledge of these.
Also a strength was its scope of enquiry, simultaneously into migraine, tension-type headache (TTH) and medication-overuse headache (MOH), the three headache disorders of major public-health importance.
This systematic review summarizes the existing data on headache and pregnancy with a scope on clinical headache phenotypes, treatment of headaches in pregnancy and effects of headache medications on the child during pregnancy and breastfeeding, headache related complications, and diagnostics of headache in pregnancy.
In 2011, WHO's global survey of headache disorders and resources, a Global Campaign project, laid bare the scale and scope of under-treated headache everywhere, and its consequences [9].
Momentum and stocks of headache tablets.
Family history of headache was reported in 28.2% of the patients with headache whereas it was 17.4% of the patients without headache (p < 0.001).
